Focal therapy using a novel cooled laser device for prostate cancer: early trial results
The PFLT-PC trial demonstrates that at 3 months, cLFT using the ProFocal device provides an 84% treatment success with low morbidity.
Authors
- Jonathan Kam (ORCID: https://orcid.org/0000-0001-6354-9664)
- Stephen McCombie (ORCID: https://orcid.org/0000-0002-6511-9382)
- Nicola Jeffery (ORCID: https://orcid.org/0000-0003-0777-6883)
- Stuart Jackson (ORCID: https://orcid.org/0000-0002-2459-8399)
- Ahmed Goolam
- Raymond Ko
- Isaac Thangasamy (ORCID: https://orcid.org/0000-0003-1820-6114)
- Jake Rahkala
- Matthew Winter (ORCID: https://orcid.org/0000-0001-6192-9874)
- George McClintock (ORCID: https://orcid.org/0000-0002-6992-8013)
- Bertram Canagasingham
- Celi Varol
- Matthew J. Roberts
- Bishoy Hanna
Institutions
- The University of Sydney (AU)
- The University of Queensland (AU)
- Chinese University of Hong Kong (HK)
- The University of Western Australia (AU)
- Royal Brisbane and Women's Hospital (AU)
- Fiona Stanley Hospital (AU)
- Nepean Hospital (AU)
- Australia New Zealand Gynaecological Oncology Group (AU)
- Medical University of Vienna (AT)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1111/bju.70150
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00